
Global & Thailand Cancer Therapeutics Market to 2031
Description
Thailand is witnessing a growing shift toward more precise, personalized, and less toxic cancer treatments. The demand for immunotherapies and targeted therapies has significantly increased, with several new treatment options entering the market. Immune checkpoint inhibitors like Keytruda (pembrolizumab) and Opdivo (nivolumab) have become more accessible in Thailand, offering promising options for patients with melanoma, non-small cell lung cancer (NSCLC), bladder cancer, and other cancers. These therapies enhance the immune system's ability to detect and attack cancer cells, providing new hope for patients with advanced-stage cancers who previously had limited options.
The Thai government has actively worked to improve access to oncology treatments through the Universal Coverage Scheme (UCS), which, as of 2023, covers chemotherapy, radiation therapy, and certain targeted therapies for all citizens. This program plays a vital role in making life-saving treatments more accessible, particularly for those living in rural or economically disadvantaged areas. Additionally, the government has taken steps to ease the financial strain of cancer care by negotiating with pharmaceutical companies to lower the cost of key cancer medications.
The Thai government has actively worked to improve access to oncology treatments through the Universal Coverage Scheme (UCS), which, as of 2023, covers chemotherapy, radiation therapy, and certain targeted therapies for all citizens. This program plays a vital role in making life-saving treatments more accessible, particularly for those living in rural or economically disadvantaged areas. Additionally, the government has taken steps to ease the financial strain of cancer care by negotiating with pharmaceutical companies to lower the cost of key cancer medications.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Thailand Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Thailand Cancer Therapeutics Market – Analysis
- 6.1 Thailand Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Thailand Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Thailand Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Thailand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Thailand Cancer Therapeutics Market Analysis – by Indications
- 8.1 Thailand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Thailand Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Thailand Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Thailand Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Thailand Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Thailand Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Thailand Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.